共 6 条
[1]
Tegaserod, a 5-HT（4） receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Muller-Lissner SA, Fumagalli I, Bardhan KD, et al. Alimentary Pharmacology and Therapeutics . 2001
[2]
The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment and prompt endoscopy. Thomson,A.B.,Barkun,A.N.,Armstrong,D. Alimentary Pharmacology and Therapeutics . 2003
[3]
Subtyping the irritable bowel syndrome by predominant bowel habit:RomeⅡversus RomeⅢ. A ERSRYD,I POSSERD,H ABRAHAMSSON,M.SIMREN. Alimentary Pharmacology and Therapeutics . 2007
[4]
Review article: tegaserod - the global experience. W. D. Chey. Alimentary Pharmacology and Therapeutics . 2004
[5]
A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant IBS. Camilleri,M,Chey,W,Mayer,E. Archives of Internal Medicine . 2001
[6]
From Rome to Los Angeles—The RomeⅢcriteria functional gI Disorders. LIN CHANG,MD. .